Medicare Enrolled
Dr. Daisy Manuel-Arguelles, DO
Family Medicine · Capitola, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Manuel-Arguelles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manuel-Arguelles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Manuel-Arguelles
Dr. Daisy Manuel-Arguelles is a family medicine specialist in Capitola, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Manuel-Arguelles performed 5,992 Medicare services across 1,471 unique beneficiaries.
Between the years covered by Open Payments, Dr. Manuel-Arguelles received a total of $16,888 from 48 pharmaceutical and/or device companies across 765 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Manuel-Arguelles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$16,888 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,992
Medicare services
Top 3% in CA for family medicine
1,471
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~315 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,840 | $18 | $31 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
803 | $67 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
235 | $98 | $283 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
131 | $12 | $45 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
105 | $144 | $289 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
98 | $3 | $14 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
88 | $34 | $60 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
81 | $47 | $135 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
79 | $71 | $130 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
70 | $77 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $153 | $393 |
| Annual depression screening | 63 | $21 | $42 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
56 | $277 | $550 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
55 | $34 | $60 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
49 | $12 | $45 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
42 | $17 | $51 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
42 | $1 | $2 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
26 | $31 | $104 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
22 | $17 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $72 | $245 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $93 | $363 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,888
Total received (2018-2024)
Avg $2,413/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
765
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,546 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$342 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,410
2023
$2,797
2022
$2,104
2021
$3,125
2020
$2,215
2019
$2,120
2018
$2,116
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,037
Novo Nordisk Inc
$243
Lilly USA, LLC
$202
PFIZER INC.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$148
Amgen Inc.
$122
Astellas Pharma US Inc
$113
GlaxoSmithKline, LLC.
$106
Bayer Healthcare Pharmaceuticals Inc.
$104
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64
AstraZeneca Pharmaceuticals LP
$43
E.R. Squibb & Sons, L.L.C.
$30
Exact Sciences Corporation
$26
Phathom Pharmaceuticals, Inc.
$21
Top 3 companies account for 61.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,713
ABBVIE INC.
$2,036
Lilly USA, LLC
$1,270
Amgen Inc.
$1,189
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,096
PFIZER INC.
$997
GlaxoSmithKline, LLC.
$944
AstraZeneca Pharmaceuticals LP
$773
Boehringer Ingelheim Pharmaceuticals, Inc.
$734
Astellas Pharma US Inc
$661
Radius Health, Inc.
$359
Bayer HealthCare Pharmaceuticals Inc.
$348
AbbVie Inc.
$330
Janssen Pharmaceuticals, Inc
$310
Merck Sharp & Dohme Corporation
$291
Biohaven Pharmaceuticals, Inc.
$286
Biohaven Pharmaceutical Holding Company Ltd.
$278
Bayer Healthcare Pharmaceuticals Inc.
$269
Teva Pharmaceuticals USA, Inc.
$203
Allergan, Inc.
$200
Allergan Inc.
$188
Jazz Pharmaceuticals Inc.
$143
Novartis Pharmaceuticals Corporation
$134
Medtronic, Inc.
$128
Amarin Pharma Inc.
$121
Eisai Inc.
$107
Collegium Pharmaceutical, Inc.
$92
E.R. Squibb & Sons, L.L.C.
$79
Edwards Lifesciences Corporation
$74
Sunovion Pharmaceuticals Inc.
$57
Merck Sharp & Dohme LLC
$56
Scilex Pharmaceuticals Inc.
$54
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$42
SANOFI-AVENTIS U.S. LLC
$34
Inspire Medical Systems, Inc.
$31
Phadia US Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$29
Exact Sciences Corporation
$26
Endo Pharmaceuticals Inc.
$22
IRONWOOD PHARMACEUTICALS, INC
$22
Phathom Pharmaceuticals, Inc.
$21
Horizon Pharma plc
$21
Bausch Health US, LLC
$20
BioDelivery Sciences International, Inc.
$19
AbbVie, Inc.
$18
Abbott Laboratories
$18
Promius Pharma LLC
$12
Takeda Pharmaceuticals U.S.A., Inc.
$5
Top 3 companies account for 35.6% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · APTIOM · AREXVY · Aimovig · BASAGLAR · BELBUCA · BELSOMRA · BEXSERO · BREO · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · GARDASIL 9 · INSPIRE · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LATUDA · LO LOESTRIN FE · LYRICA · Linzess · MOUNJARO · MOVANTIK · MYFEMBREE · MYRBETRIQ · Myrbetriq · NASCOBAL · NUCALA · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Proclaim IPG · Prolia · QULIPTA · QVAR · RAYOS · RELISTOR · RELISTOR ORAL · REYVOW · RYBELSUS · Rybelsus · SHINGRIX · SIGNIA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XTAMPZA · Xultophy 100/3.6 · Xyrem · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
569
Per 100K population
213.9
County median income
$109,266
Nearest hospital
SANTA CRUZ COUNTY PSYCHIATRIC HEALTH FACILITY
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Manuel-Arguelles is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Manuel-Arguelles experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Manuel-Arguelles performed 3,840 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manuel-Arguelles receive payments from pharmaceutical companies?
Yes. Dr. Manuel-Arguelles received a total of $16,888 from 48 companies across 765 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manuel-Arguelles's costs compare to other family medicine physicians in Capitola?
Dr. Manuel-Arguelles's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manuel-Arguelles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Capitola
Browse family medicine physicians in Capitola ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology